Pemafibrate does not lower cardiovascular risk in individuals with hypertriglyceridemia
1. In patients with type 2 diabetes and hypertriglyceridemia, pemafibrate did not alter the incidence of cardiovascular events compared to placebo. ...
Tag: fibrate